SCHEMBL30361027

SCHEMBL30361027

CC(O)COc1c(F)c(F)cc2c(=O)c(C(=O)O)c[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HTT P42858 1/20 0.38
CSNK2A2 P19784 4/20 0.38
CSNK2B P67870 4/20 0.38
CSNK2A1 P68400 4/20 0.38
CYP1A2 P05177 3/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36
MDH2 P40926 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TET2 Q6N021 1/20 0.35
TET1 Q8NFU7 1/20 0.35
MEN1 O00255 1/20 0.34
ALOX12 P18054 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29137881 1.00 ALDH1A1 (0.39) ALDH1A1HPGDKDM4EHTTCSNK2A2
SCHEMBL29137880 0.81 PRKAB2 (0.44) ALDH1A1HPGDKDM4EHTTCSNK2A2
SCHEMBL8736382 0.80 KDM4E (0.43) ALDH1A1HPGDKDM4EHTTCSNK2A2
SCHEMBL9535556 0.79 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EHTTCSNK2A2
SCHEMBL30361029 0.77 CYP1A2 (0.51) ALDH1A1HPGDKDM4ECYP1A2HSD17B10
SCHEMBL29137876 0.77 CYP1A2 (0.51) ALDH1A1HPGDKDM4ECYP1A2HSD17B10
SCHEMBL1878010 0.76 KDM4E (0.51) ALDH1A1HPGDKDM4ECSNK2A2CSNK2B
SCHEMBL13484134 0.75 CSNK2A1 (0.56) ALDH1A1HPGDKDM4EHTTCSNK2A2
SCHEMBL10760134 0.74 KDM4E (0.45) ALDH1A1HPGDKDM4EHTTCSNK2A2
SCHEMBL30307775 0.73 KDM4E (0.49) ALDH1A1HPGDKDM4EHTTCSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115850297-A Synthetic method of sarin antibiotic drug intermediate 常州兰陵制药有限公司 2023-03-28 CN claimed